Cargando…
CoVSense: Ultrasensitive Nucleocapsid Antigen Immunosensor for Rapid Clinical Detection of Wildtype and Variant SARS‐CoV‐2
The widespread accessibility of commercial/clinically‐viable electrochemical diagnostic systems for rapid quantification of viral proteins demands translational/preclinical investigations. Here, Covid‐Sense (CoVSense) antigen testing platform; an all‐in‐one electrochemical nano‐immunosensor for samp...
Autores principales: | Salahandish, Razieh, Hyun, Jae Eun, Haghayegh, Fatemeh, Tabrizi, Hamed Osouli, Moossavi, Shirin, Khetani, Sultan, Ayala‐Charca, Giancarlo, Berenger, Byron M., Niu, Yan Dong, Ghafar‐Zadeh, Ebrahim, Nezhad, Amir Sanati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214237/ https://www.ncbi.nlm.nih.gov/pubmed/36995043 http://dx.doi.org/10.1002/advs.202206615 |
Ejemplares similares
-
Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins
por: Salahandish, Razieh, et al.
Publicado: (2022) -
A compact, low-cost, and binary sensing (BiSense) platform for noise-free and self-validated impedimetric detection of COVID-19 infected patients
por: Salahandish, Razieh, et al.
Publicado: (2022) -
Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen
por: Eissa, Shimaa, et al.
Publicado: (2021) -
Sensitive sandwich-type electrochemical SARS-CoV‑2 nucleocapsid protein immunosensor
por: Karaman, Ceren, et al.
Publicado: (2021) -
Discriminative electrochemical biosensing of wildtype and omicron variant of SARS-CoV-2 nucleocapsid protein with single platform
por: Liv, Lokman, et al.
Publicado: (2022)